New research finds metformin may not treat long COVID symptoms despite early promise. Learn what studies reveal about long COVID treatment and prevention.
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from ...
New prescriptions for stimulants—mostly attention-deficit hyperactivity disorder [ADHD] drugs—doubled since the COVID-19 pandemic began among adults in Ontario, according to a study published today in ...
A new program from eMed and the NIH offers free tests and treatments, and you don't even need to leave your home.
WASHINGTON — There is no benefit to interrupting treatment with many of the available targeted synthetic or biologic disease-modifying antirheumatic drugs for rheumatoid arthritis (RA) or ...
A study reveals COVID-19 reshaped stimulant prescribing patterns in Ontario, highlighting increased ADHD diagnoses and concerns over treatment appropriateness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results